Life Healthcare Group Holdings Limited

JSE:LHC Voorraadrapport

Marktkapitalisatie: R23.2b

Life Healthcare Group Holdings Beheer

Beheer criteriumcontroles 4/4

De CEO Life Healthcare Group Holdings is Peter Wharton-Hood, benoemd in Sep2020, heeft een ambtstermijn van 4.17 jaar. De totale jaarlijkse vergoeding van { bedraagt ZAR 18.91M, bestaande uit 46.4% salaris en 53.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.18% van de aandelen van het bedrijf, ter waarde ZAR 42.31M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.2 jaar en 4.6 jaar.

Belangrijke informatie

Peter Wharton-Hood

Algemeen directeur

R18.9m

Totale compensatie

Percentage CEO-salaris46.4%
Dienstverband CEO4.2yrs
Eigendom CEO0.2%
Management gemiddelde ambtstermijn4.2yrs
Gemiddelde ambtstermijn bestuur4.6yrs

Recente managementupdates

Recent updates

Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Aug 05
Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17

May 30
Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17

Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital

Apr 20
Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital

Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Mar 18
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends

Dec 24
Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends

We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings

Nov 24
We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings

Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25

Nov 23
Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25

An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued

Sep 14
An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued

Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Aug 15
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)

Jul 31
Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)

Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?

May 19
Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?

Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital

Apr 28
Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital

An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued

Feb 08
An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued

There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Jan 25
There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For

Jan 08
With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For

Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?

Nov 28
Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?

Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?

Oct 19
Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?

Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return

Aug 16
Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return

We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt

Jul 20
We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt

Capital Allocation Trends At Life Healthcare Group Holdings (JSE:LHC) Aren't Ideal

May 14
Capital Allocation Trends At Life Healthcare Group Holdings (JSE:LHC) Aren't Ideal

How Many Life Healthcare Group Holdings Limited (JSE:LHC) Shares Did Insiders Buy, In The Last Year?

Mar 21
How Many Life Healthcare Group Holdings Limited (JSE:LHC) Shares Did Insiders Buy, In The Last Year?

Analyse CEO-vergoeding

Hoe is Peter Wharton-Hood's beloning veranderd ten opzichte van Life Healthcare Group Holdings's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2024n/an/a

R1b

Dec 31 2023n/an/a

R1b

Sep 30 2023R19mR9m

R1b

Mar 31 2023n/an/a

R1b

Dec 31 2022n/an/a

R1b

Sep 30 2022R18mR8m

R1b

Mar 31 2022n/an/a

R2b

Dec 31 2021n/an/a

R2b

Sep 30 2021R18mR8m

R2b

Mar 31 2021n/an/a

R629m

Dec 31 2020n/an/a

R668m

Sep 30 2020R8mR641k

R706m

Compensatie versus markt: De totale vergoeding ($USD 1.07M ) Peter } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de ZA markt ($USD 1.36M ).

Compensatie versus inkomsten: De vergoeding van Peter is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Peter Wharton-Hood (58 yo)

4.2yrs

Tenure

R18,907,000

Compensatie

Mr. Peter G. Wharton-Hood, (BCom (Hons) (Wits), CA(SA), AMP (Harvard)), serves as the Group Chief Executive Officer at Life Healthcare Group Holdings since September 1, 2020 and also serves as its Executiv...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Peter Wharton-Hood
Group CEO & Executive Director4.2yrsR18.91m0.18%
ZAR 42.3m
Pieter van der Westhuizen
Group CFO & Executive Director11.4yrsR13.81m0.096%
ZAR 22.4m
Adam Pyle
Chief Strategy & Growth Officer and Executive Head of Investor Relationsno dataR10.37mgeen gegevens
Craig Koekemoer
Chief Operations Officerless than a yeargeen gegevensgeen gegevens
Avanthi Parboosing
Chief People Officer3.7yrsgeen gegevensgeen gegevens
Megan Naidoo
Chief Financial Officer of South Africa4.9yrsgeen gegevensgeen gegevens
Joshila Ranchhod
Group Company Secretary3.7yrsgeen gegevensgeen gegevens
Guy Blomfield
Non-Executive Director of Life UK6.4yrsR16.34mgeen gegevens
Nick Burley
Non-Executive Director of Life UKno datageen gegevensgeen gegevens

4.2yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van LHC wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Peter Wharton-Hood
Group CEO & Executive Directorno dataR18.91m0.18%
ZAR 42.3m
Pieter van der Westhuizen
Group CFO & Executive Director11.4yrsR13.81m0.096%
ZAR 22.4m
Lars Holmqvist
Independent Non-Executive Director2.3yrsR2.84mgeen gegevens
Audrey Mothupi
Independent Non-Executive Director7.3yrsR1.03mgeen gegevens
Mahlape Sello
Lead Independent Non-Executive Director7.3yrsR1.10mgeen gegevens
Joel Netshitenzhe
Independent Non-Executive Director14yrsR852.00kgeen gegevens
Caroline Henry
Independent Non-Executive Director3.2yrsR1.19mgeen gegevens
Marian Jacobs
Independent Non-Executive Director10.8yrsR896.00kgeen gegevens
Victor Litlhakanyane
Independent Non-Executive Chairman4.6yrsR2.10m0.00069%
ZAR 160.4k
Fulvio Tonelli
Independent Non-Executive Director1.6yrsR555.00kgeen gegevens
Tebogo Moeketsi
Independent Non-Executive Director1.8yrsR627.00kgeen gegevens
Jeanne Bolger
Independent Non-Executive Director2.3yrsR2.74mgeen gegevens

4.6yrs

Gemiddelde duur

60.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van LHC wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.6 jaar).